8.02
price up icon2.69%   0.21
after-market After Hours: 8.02
loading

Maplight Therapeutics Inc Stock (MPLT) Forecast

The Maplight Therapeutics Inc (MPLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.3282, representing a +3.84% increase from the current price of $8.02. The highest analyst price target is $12.99, and the lowest is $3.6685.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MPLT Price Target
Average 19.24 (+139.92% Upside)
loading

Is Maplight Therapeutics Inc (MPLT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 24.64 Buy
STOCH(9,6) 10.38 Buy
STOCHRSI(14) 34.98 Neutral
MACD(12,26) -1.2698 Sell
ADX(14) 50.82 Sell
William %R -82.39 Buy
CCI(14) -70.33 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
8.843
Sell
8.7625
Sell
MA20
9.676
Sell
9.6618
Sell
MA50
11.32
Sell
12.83
Sell
MA100
20.43
Sell
16.73
Sell
MA200
21.04
Sell
18.26
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, MPLT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MPLT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 24.64 indicates that MPLT is oversold. This indicates that MPLT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 10.38 indicates that MPLT is oversold. This indicates that MPLT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 34.98 indicates that MPLT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 50.82 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -70.33 indicates that MPLT is still oversold but not to an extreme extent.

Long-term MPLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Maplight Therapeutics Inc financial reports and earnings history, Maplight Therapeutics Inc (MPLT) stock could reach $14.74 by 2030, $91.12 by 2040 and $151.17 by 2050. See the projected annual prices until 2050 of the Maplight Therapeutics Inc stock below:

  • Maplight Therapeutics Inc (MPLT) is expected to reach an average price of $20.21 in 2035, with a high prediction of $20.94 and a low estimate of $21.27. This indicates an $151.96% rise from the last recorded price of $8.02.
  • Maplight Therapeutics Inc (MPLT) stock is projected to chart a bullish course in 2040, with an average price target of $88.53, representing an $1,004% surge from its current level. The forecast ranges from a conservative $88.57 to a sky-high $91.12.
  • Our analysts predict Maplight Therapeutics Inc (MPLT) to jump 599.49% by 2045, soaring from $58.28 to an average price of $56.10, potentially reaching $61.22. While $58.28 is the low estimate, the potential upside is significant.
  • Maplight Therapeutics Inc (MPLT) stock is expected to climb by 2050, reaching an average of $146.01, a $1,721% jump from its current level. However, a wide range of estimates exists, with high and low targets of $151.17 and $146.57, respectively, highlighting the market's uncertainty.

Maplight Therapeutics Inc Stock (MPLT) Year by Year Forecast

Maplight Therapeutics Inc Stock (MPLT) Price Forecast for 2026

The predicted value for Maplight Therapeutics Inc (MPLT) in 2026 is set at an average of $22.05. Estimates vary from a peak of $40.43 to a trough of $3.6685, indicating an +174.93% surge from the present price of $8.02.
Month Average Low High Change from today's price
November, 2026 $12.29 $3.6685 $12.99 +53.28%
December, 2026 $8.6913 $7.5013 $13.23 +8.37%

Maplight Therapeutics Inc Stock (MPLT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Maplight Therapeutics Inc (MPLT) is $18.81, with a high forecast of $34.82 and a low forecast of $2.80. This indicates an +134.51% increase from the last price of $8.02.
Month Average Low High Change from today's price
January, 2027 $9.9398 $7.7784 $12.59 +23.94%
February, 2027 $9.8484 $7.812 $13.00 +22.80%
March, 2027 $13.32 $9.1347 $14.33 +66.07%
April, 2027 $23.08 $13.12 $26.60 +187.75%
May, 2027 $22.48 $18.94 $25.48 +180.28%
June, 2027 $22.88 $19.55 $25.25 +185.25%
July, 2027 $33.71 $22.12 $34.82 +320.26%
August, 2027 $6.5459 $3.7316 $33.75 -18.38%
September, 2027 $8.8944 $5.4701 $9.2644 +10.90%
October, 2027 $5.6429 $5.3829 $9.4265 -29.64%
November, 2027 $2.0257 $2.80 $5.7051 -74.74%
December, 2027 $1.5113 $4.1072 $2.823 -81.16%

Maplight Therapeutics Inc Stock (MPLT) Price Forecast for 2028

In 2028, Maplight Therapeutics Inc (MPLT) is projected to reach an average price of $14.63, with a high projection of $29.20 and a low estimate of $0.0656. This indicates an +82.46% rise from the last price of $8.02.
Month Average Low High Change from today's price
January, 2028 $0.6126 $0.5774 $4.9841 -92.36%
February, 2028 $2.1897 $0.2181 $4.6711 -72.70%
March, 2028 $2.4267 $0.1439 $5.5767 -69.74%
April, 2028 $4.3637 $1.9111 $7.1595 -45.59%
May, 2028 $16.40 $4.003 $19.92 +104.43%
June, 2028 $16.02 $13.52 $18.88 +99.78%
July, 2028 $16.93 $12.67 $19.23 +111.14%
August, 2028 $28.09 $16.26 $29.20 +250.25%
September, 2028 $1.5975 $1.5075 $28.21 -80.08%
October, 2028 $4.0188 $0.4303 $4.3888 -49.89%
November, 2028 $1.0958 $0.8358 $4.6331 -86.34%
December, 2028 $9.78 $0.0656 $5.8442 +21.95%

Maplight Therapeutics Inc Stock (MPLT) Price Forecast for 2029

The 2029 price forecast for Maplight Therapeutics Inc Stock (MPLT) is $12.13 on average, with a high prediction of $23.59 and a low estimate of $0.6798. This represents an +51.28% increase from the previous price of $8.02.
Month Average Low High Change from today's price
January, 2029 $6.978 $12.45 $11.39 -12.99%
February, 2029 $6.9175 $5.7653 $6.1525 -13.75%
March, 2029 $5.5169 $6.9833 $6.4561 -31.21%
April, 2029 $4.9949 $5.5599 $4.6991 -37.72%
May, 2029 $2.7294 $3.3922 $3.1236 -65.97%
June, 2029 $9.7562 $0.6798 $10.84 +21.65%
July, 2029 $9.6681 $6.9526 $13.23 +20.55%
August, 2029 $9.6737 $6.3945 $13.20 +20.62%
September, 2029 $20.00 $8.9051 $20.52 +149.37%
October, 2029 $3.6888 $3.7788 $23.59 -54.01%
November, 2029 $1.9032 $2.7532 $3.0924 -76.27%
December, 2029 $3.4512 $1.5804 $3.0012 -56.97%

Maplight Therapeutics Inc Stock (MPLT) Price Forecast for 2030

Maplight Therapeutics Inc Stock (MPLT) is expected to reach an average price of $10.04 in 2030, with a high forecast of $19.97 and a low forecast of $0.1227. This signifies an +25.24% surge from the last price of $8.02.
Month Average Low High Change from today's price
January, 2030 $18.68 $3.9648 $14.74 +132.92%
February, 2030 $20.66 $21.27 $19.97 +157.55%
March, 2030 $14.96 $14.09 $14.71 +86.56%
April, 2030 $13.35 $14.90 $14.53 +66.45%
May, 2030 $12.14 $13.11 $12.37 +51.31%
June, 2030 $11.14 $10.65 $10.46 +38.92%
July, 2030 $2.9916 $2.5683 $8.6525 -62.70%
August, 2030 $1.6557 $0.2701 $6.5501 -79.36%
September, 2030 $3.6483 $0.1227 $7.1783 -54.51%
October, 2030 $14.30 $2.9618 $14.82 +78.33%
November, 2030 $8.4535 $11.85 $17.97 +5.41%
December, 2030 $6.8609 $7.7109 $8.2965 -14.45%
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Cap:     |  Volume (24h):